Volume 16, Issue 7 (July 2018)                   IJRM 2018, 16(7): 455-458 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gholizadeh S, Jahanian Sadatmahalleh S, Ziaei S. The association between estradiol levels and cognitive function in postmenopausal women. IJRM 2018; 16 (7) :455-458
URL: http://ijrm.ir/article-1-1170-en.html
1- Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
2- Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3- Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran , Ziaei_sa@modares.ac.ir
Full-Text [PDF 378 kb]   (715 Downloads)     |   Abstract (HTML)  (2913 Views)
Full-Text:   (486 Views)
Introduction
 
As women arrive in the menopausal transition and during the early postmenopausal stage circulating levels of estradiol diminishes. Memory dysfunction is highly common during this period (1-3). While this topic remains one of ongoing debate, the basic question of whether endogenous serum of estradiol influence cognitive function remains unknown. "In older postmenopausal women, relatively higher serum estradiol levels have been associated with the better memory and global cognitive function, (4) episodic memory, (5, 6) and executive function; (7) however, there are not consistent (8, 9)." Low estrogen levels associated with Alzheimer’s disease risk in late postmenopause women, (10) however again these findings are controversial (11, 12). Few studies have determined potential links between cognitive function and serum estrogens levels in early postmenopausal women, although this period is the time when women are most likely to use hormone replacement therapy. Moreover, in this age group, studies have not found significant relations between estradiol levels and cognitive function (13, 14).
The objective of the present study was to consider whether endogenous levels of estradiol are associated with cognitive function in postmenopausal women who do not use hormone therapy.
 
Materials and methods
 
The cross-sectional study was conducted on 209 healthy postmenopausal women referred to Arash Hospital, Tehran, Iran, between November 2015 to February 2016. Sample size was calculated using coefficient 99%, power level set at 0.95, and the correlation coefficient set to detect 0.31 Pearson’s r between estradiol levels and total MoCA points. The estimated, minimum sample size was 189 participants. Thus, 209 consecutive postmenopausal women who had inclusion criteria were recruited for the study. Inclusion criteria were: 1) age: 45-65 yr, 2) intact uterus and at least one ovary, 3) menstruation interruption for at least 1 yr and not more than 10 yr, 4) serum FSH concentration over 40 IU/ml, 5) no use of hormone therapy during past six months, 6) no chronic diseases such as cancer, diabetes, hypertension, cardiovascular diseases and psychiatric diseases, 7) and no smoking.
The women filled out the MoCA (Montreal Cognitive Assessment) scale and a questionnaire containing personal data. Venous blood sample were collected in the morning after an overnight fast from the women. Levels of estradiol were estimated using electrochemiluminescence method. Then, estradiol level was tested for association with cognitive function adjusted for factors supposed to confound this association.
The MoCA was created and validated by Nasreddine and colleagues (15). It is one page 30-point test administered in approximately 10 min. The MoCA assesses several cognitive domains. The full-scale point’s range is 0-30; scores ≥26 are considered normal, while scores less than 26 are abnormal and suggestive of developing mild cognitive impairment (MCI). Psychometric properties of this scale have been studied in several studies and its validity and reliability have been confirmed (16).
 
Ethical consideration
The study was approved by the Ethics Committee of Tarbiat Modares University of Medical Sciences (EC# 523850) and all subjects gave written informed consent.
 
Statistical analysis
Estradiol levels and MoCA points were not normally distributed according to K-S test. Therefore nonparametric tests were used. First, the association between MoCA points, women age, age at menarche, age at menopause, age at first pregnancy, age at marriage, BMI and gravity with estradiol level were analyzed using Spearman Correlation test. Second, the association between educational and economic status with MoCA points were evaluated by Kruskal-Wallis test.
On stepwise multiple regression analysis, the correlation between age at first pregnancy, educational status, estradiol level, gravidity, age at marriage as independent factors, and MoCA points as a dependent factor were calculated. A 95% confidence interval (CI) was used to describe the strength of association. All statistical analyses were performed by the SPSS software (Statistical Package for the Social Sciences, version 20.0, SPSS Inc., Chicago, IL, USA). A value of p<0.05 was considered significant.
 
Results
 
The prevalence of cognitive dysfunction; MoCA points ≤26 in our participants was 62.7%, and mean±SD of estradiol level was 14.92±10.24 in participants with cognitive dysfunction in comparison with 21.67±14.92 in those with normal cognitive function. The means of age, age at menarche, age at marriage, age at first pregnancy, age at menopause, gravidity, estradiol levels, MoCA points and also socioeconomic and BMI status are shown in Table I. Table II shows the correlate between MoCA points and dependent variables of interest. MoCA points was positively associated with age at first pregnancy (p<0.001), age at marriage (p<0.001), estradiol level (p<0.001) and was negatively associated with gravidity (p<0.001).
The association between socioeconomic statuses with MoCA points is shown in Table III. High educated participants have more MoCA points (p<0.001). Table IV shows the correlation between estradiol levels and MoCA domains separately. Estradiol level was associated with short memory (p<0.001) attention (p<0.001), and executive domains (p<0.01). For better evaluation of the relationship between MoCA points as a dependent factor and mentioned independent factors, multiple regression analysis was conducted. There were significant association between MoCA points with estradiol level (p<0.01) and educational status (p<0.001) (Table V).

Table I. Demographic characteristic of the participants



Table II. Correlation between MoCA points and interested variables*


Table III. The association between socioeconomic status with MoCA points*



Table IV. Correlation between estradiol level and MoCA domains*



Table V. Stepwise multiple linear regression model for MoCA points*



Discussion
 
Our study, primary, investigate to determine whether endogenous levels of estradiol are related to specific domains of cognitive function in postmenopausal women. In our study, estradiol level was associated with short memory, attention, and executive MoCA domains. There is some evidence from the past 30 yr, presents that estradiol modulates cognitive function in animals and human. "The effect begins in uteri when estrogens guide the sexual differentiation of various brain regions controlling reproduction and some cognitive functions." Estrogen modulations on the nervous system continue through adulthood when gonadal hormone highly secrets. "It has been emphasized that estrogens can act at membrane receptors to activate intracellular signaling mechanisms that change cellular function." Also, some new documents show estrogens are synthesized locally in the brain and therefore rapidly change cognitive functions (17).
Secondary, we evaluated the association of cognitive function with socioeconomic status. Cognitive function positively correlated with age at first pregnancy; age at marriage and educational status, but negatively correlated with gravidity. Our findings are consistent with several studies that reported a positive correlation between cognitive function and educational status, (18, 19) but are inconsistent with those of other studies that reported significant positive correlation with age. (20, 21). Differences in the mean of participants, age and the usage of a variety of psychometric instruments may have contributed to this inconsistent finding. The mean of the participants' age in our study was 56.89±4.53 yr and they were in the early postmenopausal midlife period.
We found significant positive association between cognitive function with age at first pregnancy and age at marriage while it was negatively associated with gravidity. The cross-sectional associational research design limited the data interpretation to the correlational association between these variables. Moreover, these findings cannot be generalized across the postmenopausal community because of different cultural and religious status.
For better evaluation of the relationship between cognitive function as dependent variable and gravidity, age at marriage, age at first pregnancy, estradiol level and educational status as an independent variable, multiple linear regression analysis were conducted. There were associated between global cognitive function with estradiol level and educational status and there was no meaningful relationship between the other mentioned independent variables. Our findings are consistent with studies that reported a significant correlation between estradiol level and cognitive function, (4, 5, 7, 17) but are inconsistent with other studies that reported no relationship between them (14, 22, 23). In general, the relationship between estradiol level and cognitive function have generated very mixed findings. Age and gender of the participants, differences in study approach, insufficient sample size and the usage of a variety of psychometric instruments may explain these discrepancies.
We use MoCA for consideration of cognitive function. It is a brief cognitive screening tool with high specificity and sensitivity (87% and 90%, respectively) for detecting Mild Cognitive Impairment (MCI) as currently conceptualized in patients performing normally on mini-mental state examination (15).
Our study has some strength. This is a population-based study of participated women and analyses adjusted for a number of parameters that could potentially confound the association of cognitive function with hormone level. The results of our study support that postmenopausal women with higher levels of estradiol have less likely to discomfort from cognitive impairment and clinicians should evaluate the possibility of low estradiol level as a helping factor in postmenopausal women with decreased cognitive function.
 
Conclusion
 
The present observations suggest that estradiol replacement in postmenopausal women with low endogenous estradiol levels might be necessary.
 
Acknowledgments
 
We gratefully thank the participating women. This study was funded by Tarbiat Modares University, Tehran, Iran.
 
Conflict of interest
 
The authors have no conflicts of interest.






 
Type of Study: Original Article |

References
1. Henderson VW. Cognitive symptoms and disorders in the midlife women. Female Patient 2011; 36: 1-5.
2. Etgen T, Sander D, Bickel H, Forstl H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int 2011; 108: 743-750. [DOI:10.3238/arztebl.2011.0743]
3. Sturdee DW, Pines A, International Menopause Society Writing G, Archer DF, Baber RJ, Barlow D, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011; 14: 302-320. [DOI:10.3109/13697137.2011.570590]
4. Lebrun CE, van der Schouw YT, de Jong FH, Pols HA, Grobbee DE, Lamberts SW. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) 2005; 63: 50-55. [DOI:10.1111/j.1365-2265.2005.02297.x]
5. Ryan J, Stanczyk FZ, Dennerstein L, Mack WJ, Clark MS, Szoeke C, et al. Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging 2012; 33: 1138-1147. [DOI:10.1016/j.neurobiolaging.2012.04.011]
6. Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology 2004; 29: 405-421. [DOI:10.1016/S0306-4530(03)00053-2]
7. Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 2002; 41: 259-266. [DOI:10.1006/hbeh.2002.1770]
8. Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, et al. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology 2016; 87: 699-708. [DOI:10.1212/WNL.0000000000002980]
9. Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med 2015; 12: e1001833; discussion e1001833.
10. Hoskin EK, Tang MX, Manly JJ, Mayeux R. Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging 2004; 25: 141-147. [DOI:10.1016/S0197-4580(03)00046-0]
11. Maki PM, Henderson VW. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Climacteric 2012; 15: 256-262. [DOI:10.3109/13697137.2012.660613]
12. Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2008: CD003122. [DOI:10.1002/14651858.CD003122.pub2]
13. Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 2007; 14: 425-431. [DOI:10.1097/01.gme.0000247019.86748.e3]
14. Luetters C, Huang MH, Seeman T, Buckwalter G, Meyer PM, Avis NE, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN). J Womens Health (Larchmt) 2007; 16: 331-344. [DOI:10.1089/jwh.2006.0057]
15. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699. [DOI:10.1111/j.1532-5415.2005.53221.x]
16. Emsaki G, Molavi H, Chitsaz A, Movahed Abtahi M, Asgari K. Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan. J Isfahan Med Sch 2011; 29: 1391-1400. (in Persian)
17. Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav 2014; 66: 602-618. [DOI:10.1016/j.yhbeh.2014.08.011]
18. Stern Y. The concept of cognitive reserve: a catalyst for research. J Clin Exp Neuropsychol 2003; 25: 589-593. [DOI:10.1076/jcen.25.5.589.14571]
19. Nejati V. Cognitive-executive functions of brain frontal lobe in aged adults. J Behav Sci 2010; 4: 59-64. (in Persian)
20. Kempler D, Teng EL, Dick M, Taussig IM, Davis DS. The effects of age, education, and ethnicity on verbal fluency. J Int Neuropsychol Soc 1998; 4: 531-538. [DOI:10.1017/S1355617798466013]
21. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the united states: the aging, demographics, and memory study. Neuroepidemiology 2007; 29: 125-132. [DOI:10.1159/000109998]
22. Boss L, Kang DH, Bergstrom N, Leasure JL. Endogenous sex hormones and cognitive function in the elderly. Aging Clin Exp Res 2015; 27: 515-521. [DOI:10.1007/s40520-014-0300-5]
23. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 2003; 60: 1369-1371. [DOI:10.1212/01.WNL.0000059413.75888.BE]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb